Abstract
Iridocorneal endothelial (ICE) syndrome encompasses a group of rare ocular pathologies with unilateral involvement, frequently affecting young women. The disease complex includes essential iris atrophy, Chandler’s syndrome, and Cogan-Reese syndrome.
In the following article, we present a case of Iridocorneal endothelial syndrome in which a late diagnosis was made and who underwent surgery for advanced glaucoma.
Keywords: Essential iris atrophy, glaucoma, trabeculectomy
Iridocorneal Endothelial Syndrome (ICE) syndrome is a unique ophthalmic disorder that involves an abnormal corneal endothelium that leads to varying degrees of corneal edema, iris atrophy, and secondary angle-closure glaucoma [1]. This syndrome, which typically affects young women unilaterally with no family history [2], encompasses three clinical variants: Chandler Syndrome, Essential (Progressive) Iris Atrophy, Cogan-Reese Syndrome (Iris Nevus Syndrome).
The true etiology of ICE syndrome is unclear. Alvarado et al. have proposed a viral cause for the disease, based on a history of inflammation in certain cases and on the presence of inflammatory cells on histological analysis [3]. Further exploring this hypothesis, the same author revealed Herpes Simplex DNA in the pathological corneas by using the PCR (Polymerase Chain Reaction) technique [4].
The pathological elements observed in the endothelium are the most important clinical findings seen in ICE syndrome, namely “the ICE cell” which is pathognomonic. These cells are abnormally large and show increased pleomorphism [5]. Desmosomes, tonofilaments and numerous microvilli (100 versus 10 in a normal endothelial cell) [3], have all been identified by means of electronic microscopy, proving that the ICE cell shows epithelial-like characteristics [6]. The abnormal endothelial cells may migrate posteriorly, forming a membrane that covers the adjacent structures, iris and trabecular meshwork [7]. The contraction of this membrane leads to characteristic iris changes, iridotrabecular synechiae, corectopia with the pupil being drawn towards the area where the synechiae are most prevalent and to secondary angle-closure glaucoma [5]. Glaucoma may appear in the absence of synechiae, because of the membrane migration phenomenon that can functionally close the angle, but still allow for an open angle on gonioscopy [2]. Hence, the degree of angle closure is not associated with the IOP level [8].
History
A 43-year-old female, with no relevant familial history, was admitted to our clinic for blurred vision in her left eye, reevaluation and treatment. The patient had been admitted to a clinic in Vienna six weeks prior for blurred vision in her left eye, nausea drowsiness and vomiting.
Upon examination in Vienna, the patient had BCVA 0,2 OS, IOP OS 80mmHg. After managing the acute phase, clinical examination showed temporal pupil traction, pigment dispersion on the endothelium and cup-disk ratio 0,9. The patient was investigated (Fig. 1 Humphrey Visual Field) and released with the diagnosis of OS Rieger Anomaly. Secondary Glaucoma and maximal glaucoma topical medication (β-blocker, CAI, prostaglandin analogue, α2-agonist).
Fig. 1.

Humphrey Visual Field OS upon discharge from Vienna. MD=-5.02dB
After 2 weeks, the patient was admitted to a county hospital in Romania with a BCVA 0,3 OS and IOP OS 43mmHg with treatment. Gonioscopy revealed a partially closed angle, CCT was 604µm and cup-disk ratio 0,8.
The patient received i.v. Mannitol 20% (after which IOP OS dropped to 18mmHg), underwent a second visual field analysis (Fig. 2) and was referred to our clinic with the presumed diagnoses OS Posttraumatic glaucoma? Iridodialysis? Acute angle-closure glaucoma 2 weeks prior?
Fig. 2.

Humphrey Visual Field upon discharge from the county hospital. MD=-15.01dB
Clinical examination
Upon admission to our clinic, the patient was in good health and her BCVA was of 0,6 OS and IOP OS 20mmHg.
Slit-lamp examination: pigment dispersion on the endothelium and anterior lens capsule, ectropion uvea, semi-mydriatic pupil with superior traction, corectopia and dyscoria, iris heterochromia, total temporal iris defect with pseudopolycoria, diffuse iris stromal atrophy, and PAS (peripheral anterior synechiae) at 11 and 1 o’clock (Fig. 3).
Fig. 3.

Anterior segment OS
On gonioscopy, the angle was completely closed and the cup-disk ratio was 0,9 with nasal shifting of central vessels and peri-papillary atrophy (Fig. 4).
Fig. 4.

Posterior pole OS
A clinical diagnosis of OS ICE syndrome with secondary glaucoma was made.
Ancillary testing
Visual field analysis, optic nerve head OCT (Fig. 5) and specular microscopy (Fig. 6) were performed.
Fig. 5.

The ONH OCT shows marked loss of RNFL fibers in the temporal, inferior, and superior sector (in this order)
Fig. 6.

Specular microscopy – endothelial cell count – shows polymegathism with a significant rise in the mean cell area (695.8µm2) compared to the normal value (537.0 ± 137.4 μm2) [9] and to the other eye (307.6 µm2)
A final diagnosis was made based on the epidemiological data (unilateral symptoms in a young female with no family history), patient history (sudden onset), clinical examination (ocular symptoms with no systemic manifestations), and ancillary tests (specular microscopy being useful).
The final diagnosis was OS Essential Iris Atrophy (ICE Syndrome) with secondary glaucoma.
Follow-up and management
Surgery was recommended because of uncontrolled IOP in spite of maximal local treatment. A combined trabeculotomy-trabeculectomy with peripheral iridectomy was performed.
Surgery was uneventful and the following morning IOP OS was of 19mmHg with a medium anterior chamber depth. Glaucoma medication was stopped.
At the one month follow-up, BCVA OS was 0,6, IOP OS was 18mmHg without treatment, the ACD (anterior chamber depth) was medium and the filtering bleb was functional (Fig. 7).
Fig. 7.

Postoperative anterior segment OS
At the 4 months follow-up, BCVA OS was 0,6, IOP OS was 20mmHg without treatment, the ACD was medium and the filtering bleb was functional. A visual field was performed, which showed MD=-19.21dB and the patient was given topical medication (fixed combination dorzolamide-timolol).
Discussion
Trabeculectomy is the surgery of choice for ICE syndrome. Shields et al. have reported a 69% success rate in a study conducted in 1978 on 33 eyes [10], while Yanoff reported a 64% success rate 1 year postoperatively and a 36% at 3 years [8]. When the trabeculectomy proves to be ineffective, the reason is usually excessive subconjunctival scarring [11] (a frequent occurrence in patients with ICE syndrome, given their young age). ICE-specific phenomena that lead to failure are bleb and/ or filtering ostium endothelialization [12] and PAS formation that obstruct the drainage pathway.
Case particularity
This case stands out due to its complexity and the controversies associated with it (3 different diagnoses from 3 different clinics). A long-term follow-up is necessary because the disease itself is progressive in nature. Studies suggest follow-up at 2-3 months intervals when glaucoma is associated and depending on its severity. Serologic testing is also recommended (Epstein-Barr and Herpes Simplex viruses) [13].
References
- 1.Yanoff M, Duker JS. Ophthalmology. 2013 [Google Scholar]
- 2.Primary Angle Closure – Preferred Practice Pattern Guidelines. American Academy of Ophthalmology. 2010 [Google Scholar]
- 3.Alvarodo JA, Murphy CG, Jusrer RP, Herheringron J. Pafhogenesis of Chandler’s Syndrome, Essential Iris Atrophy and the Cogan-Reese Syndrome. Estimated Age or Disease Onset. Invest. Ophthalmol. Vis. Sci. 1986 [PubMed] [Google Scholar]
- 4.Alvarodo JA, et al. Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch. Ophthalmol. 1994;112:1601–1609. doi: 10.1001/archopht.1994.01090240107034. [DOI] [PubMed] [Google Scholar]
- 5.Yanoff M, Sassani J. Ocular Pathology. Mosby, Inc.; 2009. [Google Scholar]
- 6.Levy SG, Kirkness CM, Moss J, Ficker L, McCartney AC. The histopathology of the iridocorneal-endothelial syndrome. Cornea. 1996;15:46–54. [PubMed] [Google Scholar]
- 7.Hirst LW, Quigley HA, Stark WJ, Shields MB. Specular microscopy of iridocorneal endothelia syndrome. Am. J. Ophthalmol. 1980;89:11–21. doi: 10.1016/0002-9394(80)90223-8. [DOI] [PubMed] [Google Scholar]
- 8.Yanoff M, Duker JS. Ophthalmology. 2004 [Google Scholar]
- 9.Hashemian MN, Moghimi S, Fard MA, Fallah MR, Mansouri MR. Corneal endothelial cell density and morphology in normal Iranian eyes. BMC Ophthalmol. 2006;6:9. doi: 10.1186/1471-2415-6-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bruce Shields M, Campbell DG, Simmons RJ. The Essential Iris Atrophies. Am. J. Ophthalmol. 1978;85:749–759. doi: 10.1016/s0002-9394(14)78101-2. [DOI] [PubMed] [Google Scholar]
- 11.Hong B. Intracameral injection of tissue plasminogen activator to treat severe post-operative fibrinous reaction in iridocorneal endothelial syndrome. Digit. J. Ophthalmol. 2013;90033 doi: 10.5693/djo.02.2013.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yanoff M, Scheie HG, Allman MI. Endothelialization of Filtering Bleb in Iris Nevus Syndrome. Arch. Ophthalmol. 1976;94:1933–1936. doi: 10.1001/archopht.1976.03910040639012. [DOI] [PubMed] [Google Scholar]
- 13.Alvarado JA. Detection of Herpes Simplex Viral DNA in the Iridocorneal Endothelial Syndrome. Arch. Ophthalmol. 1994;112:1601. doi: 10.1001/archopht.1994.01090240107034. [DOI] [PubMed] [Google Scholar]
